{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:56:12Z","timestamp":1794459372079,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-022-00652-3","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T16:04:43Z","timestamp":1666281883000},"page":"1245-1259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Innate metabolic responses against viral infections"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9822-4181","authenticated-orcid":false,"given":"Clovis. S.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fimmu.2017.01311","volume":"8","author":"HM Shehata","year":"2017","unstructured":"Shehata, H. M. et al. Sugar or Fat? Metabolic requirements for immunity to viral infections. Front Immunol. 8, 1311 (2017).","journal-title":"Front Immunol."},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2893.2011.01554.x","volume":"19","author":"M Stepanova","year":"2012","unstructured":"Stepanova, M., Lam, B., Younossi, Y., Srishord, M. K. & Younossi, Z. M. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J. Viral Hepat. 19, 341\u2013345 (2012).","journal-title":"J. Viral Hepat."},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis. Cell Metab. 32, 437\u2013446 (2020).","journal-title":"Cell Metab."},{"key":"652_CR4","doi-asserted-by":"publisher","unstructured":"Duette, G. et al. Induction of HIF-1\u03b1 by HIV-1 infection in CD4+ T cells promotes viral replication and drives extracellular vesicle-mediated inflammation. mBio https:\/\/doi.org\/10.1128\/mBio.00757-18 (2018).","DOI":"10.1128\/mBio.00757-18"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"715208","DOI":"10.3389\/fcimb.2021.715208","volume":"11","author":"A Lahon","year":"2021","unstructured":"Lahon, A., Arya, R. P. & Banerjea, A. C. Dengue virus dysregulates master transcription factors and PI3K\/AKT\/mTOR signaling pathway in megakaryocytes. Front. Cell. Infect. Microbiol. 11, 715208 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","volume":"320","author":"S Ajaz","year":"2021","unstructured":"Ajaz, S. et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am. J. Physiol. Cell Physiol. 320, C57\u2013C65 (2021).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"e2122897119","DOI":"10.1073\/pnas.2122897119","volume":"119","author":"C Qin","year":"2022","unstructured":"Qin, C. et al. SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis. Proc. Natl Acad. Sci. USA 119, e2122897119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"652_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24007-w","volume":"12","author":"NC Gassen","year":"2021","unstructured":"Gassen, N. C. et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat. Commun. 12, 3818 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR9","doi-asserted-by":"crossref","unstructured":"Palmer, C. S. et al. Increased glucose metabolic activity is associated with CD4+ T cell activation and depletion during chronic HIV infection. AIDS 28, 297\u2013309 (2014).","DOI":"10.1097\/QAD.0000000000000128"},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.4049\/jimmunol.1303092","volume":"193","author":"CS Palmer","year":"2014","unstructured":"Palmer, C. S. et al. Glut1 expressing proinflammatory monocytes are elevated in cART-treated and untreated HIV-1+ subjects. J. Immunol. 193, 5595\u20135603 (2014).","journal-title":"J. Immunol."},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2018.11.015","volume":"29","author":"JC Valle-Casuso","year":"2019","unstructured":"Valle-Casuso, J. C. et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab. 29, 611\u2013626 (2019).","journal-title":"Cell Metab."},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"107810","DOI":"10.1016\/j.celrep.2020.107810","volume":"31","author":"HE Taylor","year":"2020","unstructured":"Taylor, H. E. et al. mTOR overcomes multiple metabolic restrictions to enable HIV-1 reverse transcription and intracellular transport. Cell Rep. 31, 107810 (2020).","journal-title":"Cell Rep."},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1073\/pnas.1121427109","volume":"109","author":"S Loisel-Meyer","year":"2012","unstructured":"Loisel-Meyer, S. et al. Glut1-mediated glucose transport regulates HIV infection. Proc. Natl Acad. Sci. USA 109, 2549\u20132554 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1080\/15384101.2016.1190054","volume":"15","author":"PK Datta","year":"2016","unstructured":"Datta, P. K. et al. Glutamate metabolism in HIV-1-infected macrophages: role of HIV-1 Vpr. Cell Cycle 15, 2288\u20132298 (2016).","journal-title":"Cell Cycle"},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2016.02.012","volume":"6","author":"CS Palmer","year":"2016","unstructured":"Palmer, C. S., Cherry, C. L., Sada-Ovalle, I., Singh, A. & Crowe, S. M. Glucose metabolism in T cells and monocytes: new perspectives in HIV pathogenesis. EBioMedicine 6, 31\u201341 (2016).","journal-title":"EBioMedicine"},{"key":"652_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22166-4","volume":"12","author":"PJ Mullen","year":"2021","unstructured":"Mullen, P. J. et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat. Commun. 12, 1876 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1042\/CS20201042","volume":"135","author":"SM Hirabara","year":"2021","unstructured":"Hirabara, S. M. et al. Host cell glutamine metabolism as a potential antiviral target. Clin. Sci. 135, 305\u2013325 (2021).","journal-title":"Clin. Sci."},{"key":"652_CR18","doi-asserted-by":"crossref","unstructured":"Clerc, I. et al. Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4+ T cells. Nat. Metab. 1, 717\u2013730 (2019).","DOI":"10.1038\/s42255-019-0084-1"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"725043","DOI":"10.3389\/fcimb.2021.725043","volume":"11","author":"FJ S\u00e1nchez-Garc\u00eda","year":"2021","unstructured":"S\u00e1nchez-Garc\u00eda, F. J., P\u00e9rez-Hern\u00e1ndez, C. A., Rodr\u00edguez-Murillo, M. & Moreno-Altamirano, M. M. B. The role of tricarboxylic acid cycle metabolites in viral infections. Front Cell. Infect. Microbiol. 11, 725043 (2021).","journal-title":"Front Cell. Infect. Microbiol."},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis. Cell Metab. 32, 437\u2013446 (2020).","journal-title":"Cell Metab."},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","volume":"3","author":"EL Mills","year":"2021","unstructured":"Mills, E. L. et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat. Metab. 3, 604\u2013617 (2021).","journal-title":"Nat. Metab."},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","volume":"22","author":"AV Menk","year":"2018","unstructured":"Menk, A. V. et al. Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions. Cell Rep. 22, 1509\u20131521 (2018).","journal-title":"Cell Rep."},{"key":"652_CR23","doi-asserted-by":"crossref","unstructured":"Reina-Campos, M., Scharping, N. E. & Goldrath, A. W. CD8+ T cell metabolism in infection and cancer. Nat. Rev. Immunol. 21, 718\u2013738 (2021).","DOI":"10.1038\/s41577-021-00537-8"},{"key":"652_CR24","doi-asserted-by":"crossref","unstructured":"Kinet, S. et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 4, 31 (2007).","DOI":"10.1186\/1742-4690-4-31"},{"key":"652_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","volume":"115","author":"N Manel","year":"2003","unstructured":"Manel, N. et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449\u2013459 (2003).","journal-title":"Cell"},{"key":"652_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep21808","volume":"6","author":"JJ Cheng","year":"2016","unstructured":"Cheng, J. J. et al. CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Sci. Rep. 6, 21808 (2016).","journal-title":"Sci. Rep."},{"key":"652_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nm.2238","volume":"16","author":"E Herker","year":"2010","unstructured":"Herker, E. et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat. Med. 16, 1295\u20131298 (2010).","journal-title":"Nat. Med."},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"e02168","DOI":"10.1128\/JVI.02168-16","volume":"91","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Epstein\u2013Barr virus-encoded latent membrane protein 1 upregulates glucose transporter 1 transcription via the mTORC1\/NF-\u03baB signaling pathways. J. Virol. 91, e02168\u201316 (2017).","journal-title":"J. Virol."},{"key":"652_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9873","volume":"6","author":"M Thai","year":"2015","unstructured":"Thai, M. et al. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat. Commun. 6, 8873 (2015).","journal-title":"Nat. Commun."},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1128\/JVI.02123-09","volume":"84","author":"JW Chambers","year":"2010","unstructured":"Chambers, J. W., Maguire, T. G. & Alwine, J. C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 84, 1867\u20131873 (2010).","journal-title":"J. Virol."},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"110118","DOI":"10.1016\/j.celrep.2021.110118","volume":"37","author":"C Yau","year":"2021","unstructured":"Yau, C. et al. Dysregulated metabolism underpins Zika-virus-infection-associated impairment in fetal development. Cell Rep. 37, 110118 (2021).","journal-title":"Cell Rep."},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.27159","volume":"60","author":"N Oehler","year":"2014","unstructured":"Oehler, N. et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 60, 1483\u20131493 (2014).","journal-title":"Hepatology"},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1099\/vir.0.052928-0","volume":"94","author":"S Shimode","year":"2013","unstructured":"Shimode, S., Nakaoka, R., Shogen, H. & Miyazawa, T. Characterization of feline ASCT1 and ASCT2 as RD-114 virus receptor. J. Gen. Virol. 94, 1608\u20131612 (2013).","journal-title":"J. Gen. Virol."},{"key":"652_CR34","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1128\/JVI.73.5.4470-4474.1999","volume":"73","author":"CS Tailor","year":"1999","unstructured":"Tailor, C. S., Nouri, A., Zhao, Y., Takeuchi, Y. & Kabat, D. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73, 4470\u20134474 (1999).","journal-title":"J. Virol."},{"key":"652_CR35","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/JVI.76.13.6442-6452.2002","volume":"76","author":"D Lavillette","year":"2002","unstructured":"Lavillette, D. et al. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters\/cell surface receptors. J. Virol. 76, 6442\u20136452 (2002).","journal-title":"J. Virol."},{"key":"652_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10587-1","volume":"10","author":"KR Stein","year":"2019","unstructured":"Stein, K. R. et al. CD46 facilitates entry and dissemination of human cytomegalovirus. Nat. Commun. 10, 2699 (2019).","journal-title":"Nat. Commun."},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","volume":"77","author":"A Segerman","year":"2003","unstructured":"Segerman, A. et al. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77, 9183\u20139191 (2003).","journal-title":"J. Virol."},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.chom.2009.09.006","volume":"6","author":"PE Joubert","year":"2009","unstructured":"Joubert, P. E. et al. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 6, 354\u2013366 (2009).","journal-title":"Cell Host Microbe"},{"key":"652_CR39","doi-asserted-by":"crossref","unstructured":"Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during TH1 cell responses. Immunity 42, 1033\u20131047 (2015).","DOI":"10.1016\/j.immuni.2015.05.024"},{"key":"652_CR40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"652_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501\u2013521 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"652_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"JD Domizio","year":"2022","unstructured":"Domizio, J. D. et al. The cGAS\u2013STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145\u2013151 (2022).","journal-title":"Nature"},{"key":"652_CR43","doi-asserted-by":"publisher","first-page":"e201800282","DOI":"10.26508\/lsa.201800282","volume":"2","author":"T Imanishi","year":"2019","unstructured":"Imanishi, T. et al. Reciprocal regulation of STING and TCR signaling by mTORC1 for T cell activation and function. Life Sci. Alliance 2, e201800282 (2019).","journal-title":"Life Sci. Alliance"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.3433","volume":"17","author":"F Wang","year":"2016","unstructured":"Wang, F. et al. S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3. Nat. Immunol. 17, 514\u2013522 (2016).","journal-title":"Nat. Immunol."},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"e00784","DOI":"10.1128\/JVI.00784-19","volume":"93","author":"N Meade","year":"2019","unstructured":"Meade, N., King, M., Munger, J. & Walsh, D. mTOR dysregulation by vaccinia virus F17 controls multiple processes with varying roles in infection. J. Virol. 93, e00784\u201319 (2019).","journal-title":"J. Virol."},{"key":"652_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.celrep.2015.05.046","volume":"12","author":"JS Moon","year":"2015","unstructured":"Moon, J. S. et al. mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 12, 102\u2013115 (2015).","journal-title":"Cell Rep."},{"key":"652_CR47","doi-asserted-by":"publisher","first-page":"630380","DOI":"10.3389\/fimmu.2021.630380","volume":"12","author":"HC Lin","year":"2021","unstructured":"Lin, H. C. et al. Lactic acid fermentation is required for NLRP3 inflammasome activation. Front. Immunol. 12, 630380 (2021).","journal-title":"Front. Immunol."},{"key":"652_CR48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature11290","volume":"488","author":"B Lu","year":"2012","unstructured":"Lu, B. et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670\u2013674 (2012).","journal-title":"Nature"},{"key":"652_CR49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-022-01185-3","volume":"23","author":"LK Billingham","year":"2022","unstructured":"Billingham, L. K. et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat. Immunol. 23, 692\u2013704 (2022).","journal-title":"Nat. Immunol."},{"key":"652_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140 (2010).","journal-title":"Nat. Immunol."},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674\u2013677 (2008).","journal-title":"Science"},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","volume":"54","author":"H Xian","year":"2021","unstructured":"Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463\u20131477 (2021).","journal-title":"Immunity"},{"key":"652_CR53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/ijbs.29680","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy. Int. J. Biol. Sci. 15, 1010\u20131019 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"652_CR54","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1002\/jcp.27616","volume":"234","author":"F Al-Hashem","year":"2019","unstructured":"Al-Hashem, F. et al. Metformin inhibits mTOR\u2013HIF-1\u03b1 axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J. Cell. Physiol. 234, 9328\u20139337 (2019).","journal-title":"J. Cell. Physiol."},{"key":"652_CR55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33, 1013\u20131026 (2021).","journal-title":"Cell Metab."},{"key":"652_CR56","doi-asserted-by":"publisher","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2021","unstructured":"Rodrigues, T. S. et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 218, e20201707 (2021).","journal-title":"J. Exp. Med."},{"key":"652_CR57","doi-asserted-by":"publisher","first-page":"686240","DOI":"10.3389\/fimmu.2021.686240","volume":"12","author":"LB Giron","year":"2021","unstructured":"Giron, L. B. et al. Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12, 686240 (2021).","journal-title":"Front. Immunol."},{"key":"652_CR58","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","volume":"32","author":"A Hooftman","year":"2020","unstructured":"Hooftman, A. et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 32, 468\u2013478 (2020).","journal-title":"Cell Metab."},{"key":"652_CR59","doi-asserted-by":"publisher","first-page":"e1010219","DOI":"10.1371\/journal.ppat.1010219","volume":"18","author":"A Sohail","year":"2022","unstructured":"Sohail, A. et al. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog. 18, e1010219 (2022).","journal-title":"PLoS Pathog."},{"key":"652_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier, D. et al. SARS-CoV-2-mediated suppression of NRF2 signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 11, 4938 (2020).","journal-title":"Nat. Commun."},{"key":"652_CR61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481\u2013485 (2011).","journal-title":"Nature"},{"key":"652_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s42255-021-00507-3","volume":"4","author":"C Brenner","year":"2022","unstructured":"Brenner, C. Viral infection as an NAD+ battlefield. Nat. Metab. 4, 2\u20133 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR63","doi-asserted-by":"publisher","first-page":"26642","DOI":"10.1074\/jbc.M114.589515","volume":"289","author":"I Welsby","year":"2014","unstructured":"Welsby, I. et al. PARP12, an interferon-stimulated gene involved in the control of protein translation and inflammation. J. Biol. Chem. 289, 26642\u201326657 (2014).","journal-title":"J. Biol. Chem."},{"key":"652_CR64","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.4049\/jimmunol.1701117","volume":"200","author":"G Caprara","year":"2018","unstructured":"Caprara, G. et al. PARP14 controls the nuclear accumulation of a subset of type I IFN-inducible proteins. J. Immunol. 200, 2439\u20132454 (2018).","journal-title":"J. Immunol."},{"key":"652_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13578-021-00628-y","volume":"11","author":"L Li","year":"2021","unstructured":"Li, L. et al. ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12. Cell Biosci. 11, 116 (2021).","journal-title":"Cell Biosci."},{"key":"652_CR66","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","volume":"155","author":"AP Gomes","year":"2013","unstructured":"Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear\u2013mitochondrial communication during aging. Cell 155, 1624\u20131638 (2013).","journal-title":"Cell"},{"key":"652_CR67","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaf2693","volume":"352","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436\u20131443 (2016).","journal-title":"Science"},{"key":"652_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/rej.2018.2077","volume":"22","author":"J Clement","year":"2019","unstructured":"Clement, J., Wong, M., Poljak, A., Sachdev, P. & Braidy, N. The plasma NAD+ metabolome is dysregulated in \u2018normal\u2019 aging. Rejuvenation Res. 22, 121\u2013130 (2019).","journal-title":"Rejuvenation Res."},{"key":"652_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21907-9","volume":"12","author":"N Xiao","year":"2021","unstructured":"Xiao, N. et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 12, 1618 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR70","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2018.02.009","volume":"30","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and proinflammatory activity. EBioMedicine 30, 303\u2013316 (2018).","journal-title":"EBioMedicine"},{"key":"652_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1336-4","volume":"10","author":"T Vigo","year":"2019","unstructured":"Vigo, T. et al. IFN-\u03b2 enhances mesenchymal stromal (stem) cells immunomodulatory function through STAT1\u20133 activation and mTOR-associated promotion of glucose metabolism. Cell Death Dis. 10, 85 (2019).","journal-title":"Cell Death Dis."},{"key":"652_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16571-4","volume":"11","author":"CC Chan","year":"2020","unstructured":"Chan, C. C. et al. Type I interferon sensing unlocks dormant adipocyte inflammatory potential. Nat. Commun. 11, 2745 (2020).","journal-title":"Nat. Commun."},{"key":"652_CR73","doi-asserted-by":"publisher","unstructured":"Aliyari, S. R. et al. Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2. Acta Pharm. Sin. B https:\/\/doi.org\/10.1016\/j.apsb.2022.02.019 (2022).","DOI":"10.1016\/j.apsb.2022.02.019"},{"key":"652_CR74","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.immuni.2019.10.014","volume":"51","author":"A Lercher","year":"2019","unstructured":"Lercher, A. et al. Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function. Immunity 51, 1074\u20131087 (2019).","journal-title":"Immunity"},{"key":"652_CR75","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"652_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457\u2013470 (2016).","journal-title":"Cell"},{"key":"652_CR77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"652_CR78","doi-asserted-by":"publisher","first-page":"108756","DOI":"10.1016\/j.celrep.2021.108756","volume":"34","author":"M Bambouskova","year":"2021","unstructured":"Bambouskova, M. et al. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 34, 108756 (2021).","journal-title":"Cell Rep."},{"key":"652_CR79","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","volume":"135","author":"JB Regard","year":"2008","unstructured":"Regard, J. B., Sato, I. T. & Coughlin, S. R. Anatomical profiling of G-protein-coupled receptor expression. Cell 135, 561\u2013571 (2008).","journal-title":"Cell"},{"key":"652_CR80","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.1074\/jbc.REV120.012784","volume":"295","author":"S Ghosh","year":"2020","unstructured":"Ghosh, S. & Marsh, E. N. G. Viperin: an ancient radical SAM enzyme finds its place in modern cellular metabolism and innate immunity. J. Biol. Chem. 295, 11513\u201311528 (2020).","journal-title":"J. Biol. Chem."},{"key":"652_CR81","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-018-0238-4","volume":"558","author":"AS Gizzi","year":"2018","unstructured":"Gizzi, A. S. et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature 558, 610\u2013614 (2018).","journal-title":"Nature"},{"key":"652_CR82","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/1873-3468.13778","volume":"594","author":"K Honarmand Ebrahimi","year":"2020","unstructured":"Honarmand Ebrahimi, K., Vowles, J., Browne, C., McCullagh, J. & James, W. S. ddhCTP produced by the radical-SAM activity of RSAD2 (viperin) inhibits the NAD+-dependent activity of enzymes to modulate metabolism. FEBS Lett. 594, 1631\u20131644 (2020).","journal-title":"FEBS Lett."},{"key":"652_CR83","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42255-022-00550-8","volume":"4","author":"EC Britt","year":"2022","unstructured":"Britt, E. C. et al. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils. Nat. Metab. 4, 389\u2013403 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-020-00539-9","volume":"17","author":"N Kishimoto","year":"2020","unstructured":"Kishimoto, N. et al. Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration. Retrovirology 17, 31 (2020).","journal-title":"Retrovirology"},{"key":"652_CR85","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"652_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"652_CR87","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.4049\/jimmunol.2100488","volume":"207","author":"C Diskin","year":"2021","unstructured":"Diskin, C. et al. 4-octyl-itaconate and dimethyl fumarate inhibit COX2 expression and prostaglandin production in macrophages. J. Immunol. 207, 2561\u20132569 (2021).","journal-title":"J. Immunol."},{"key":"652_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07179-w","volume":"9","author":"LA Murray","year":"2018","unstructured":"Murray, L. A., Sheng, X. & Cristea, I. M. Orchestration of protein acetylation as a toggle for cellular defense and virus replication. Nat. Commun. 9, 4967 (2018).","journal-title":"Nat. Commun."},{"key":"652_CR89","doi-asserted-by":"publisher","first-page":"e108306","DOI":"10.15252\/embj.2021108306","volume":"41","author":"A Guillon","year":"2022","unstructured":"Guillon, A. et al. Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein. EMBO J. 41, e108306 (2022).","journal-title":"EMBO J."},{"key":"652_CR90","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/cei.12591","volume":"180","author":"MJ Ashbrook","year":"2015","unstructured":"Ashbrook, M. J. et al. Citrate modulates lipopolysaccharide-induced monocyte inflammatory responses. Clin. Exp. Immunol. 180, 520\u2013530 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"652_CR91","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","volume":"9","author":"NC Williams","year":"2018","unstructured":"Williams, N. C. & O\u2019Neill, L. A. J. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141 (2018).","journal-title":"Front. Immunol."},{"key":"652_CR92","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","volume":"29","author":"DA Cappel","year":"2019","unstructured":"Cappel, D. A. et al. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab. 29, 1291\u20131305 (2019).","journal-title":"Cell Metab."},{"key":"652_CR93","doi-asserted-by":"publisher","first-page":"e1002124","DOI":"10.1371\/journal.ppat.1002124","volume":"7","author":"L Vastag","year":"2011","unstructured":"Vastag, L., Koyuncu, E., Grady, S. L., Shenk, T. E. & Rabinowitz, J. D. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 7, e1002124 (2011).","journal-title":"PLoS Pathog."},{"key":"652_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20316-8","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou, L. et al. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat. Commun. 12, 98 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR95","doi-asserted-by":"publisher","unstructured":"Hicks, K. G. et al. Protein-metabolite interactomics reveals novel regulation of carbohydrate metabolism. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.08.28.458030 (2021).","DOI":"10.1101\/2021.08.28.458030"},{"key":"652_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.20709","volume":"59","author":"A Garcia-Cazorla","year":"2006","unstructured":"Garcia-Cazorla, A. et al. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann. Neurol. 59, 121\u2013127 (2006).","journal-title":"Ann. Neurol."},{"key":"652_CR97","doi-asserted-by":"publisher","first-page":"e1004864","DOI":"10.1371\/journal.ppat.1004864","volume":"11","author":"HE Taylor","year":"2015","unstructured":"Taylor, H. E. et al. Phospholipase D1 couples CD4+ T cell activation to c-Myc-dependent deoxyribonucleotide pool expansion and HIV-1 replication. PLoS Pathog. 11, e1004864 (2015).","journal-title":"PLoS Pathog."},{"key":"652_CR98","doi-asserted-by":"crossref","unstructured":"Taylor, H. E. & Palmer, C. S. CD4+ T cell metabolism is a major contributor of HIV infectivity and reservoir persistence. Immunometabolism 2, e200005 (2020).","DOI":"10.20900\/immunometab20200005"},{"key":"652_CR99","doi-asserted-by":"publisher","first-page":"e13314","DOI":"10.15252\/emmm.202013314","volume":"13","author":"S Singh","year":"2021","unstructured":"Singh, S. et al. Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potential. EMBO Mol. Med. 13, e13314 (2021).","journal-title":"EMBO Mol. Med."},{"key":"652_CR100","doi-asserted-by":"publisher","first-page":"e13901","DOI":"10.15252\/emmm.202013901","volume":"13","author":"IL Shytaj","year":"2021","unstructured":"Shytaj, I. L. et al. Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress. EMBO Mol. Med. 13, e13901 (2021).","journal-title":"EMBO Mol. Med."},{"key":"652_CR101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2021.02.071","volume":"549","author":"N Kishimoto","year":"2021","unstructured":"Kishimoto, N. et al. Glucose-dependent aerobic glycolysis contributes to recruiting viral components into HIV-1 particles to maintain infectivity. Biochem. Biophys. Res. Commun. 549, 187\u2013193 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"652_CR102","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-021-00898-1","volume":"22","author":"H Guo","year":"2021","unstructured":"Guo, H. et al. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication. Nat. Immunol. 22, 423\u2013433 (2021).","journal-title":"Nat. Immunol."},{"key":"652_CR103","doi-asserted-by":"publisher","unstructured":"Valle-Casuso, J. C. et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2018.11.015 (2018).","DOI":"10.1016\/j.cmet.2018.11.015"},{"key":"652_CR104","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1089\/aid.2017.0165","volume":"33","author":"A Hegedus","year":"2017","unstructured":"Hegedus, A. et al. Evidence for altered glutamine metabolism in human immunodeficiency virus type 1 infected primary human CD4+ T cells. AIDS Res. Hum. Retroviruses 33, 1236\u20131247 (2017).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"652_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0368-z","volume":"14","author":"MM Kulkarni","year":"2017","unstructured":"Kulkarni, M. M. et al. Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology 14, 45 (2017).","journal-title":"Retrovirology"},{"key":"652_CR106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.12688\/f1000research.11881.1","volume":"7","author":"CS Palmer","year":"2018","unstructured":"Palmer, C. S., Palchaudhuri, R., Albargy, H., Abdel-Mohsen, M. & Crowe, S. M. Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging. F1000Research 7, 125 (2018).","journal-title":"F1000Research"},{"key":"652_CR107","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/21623945.2019.1609202","volume":"8","author":"J Couturier","year":"2019","unstructured":"Couturier, J. et al. Lymphocytes upregulate CD36 in adipose tissue and liver. Adipocyte 8, 154\u2013163 (2019).","journal-title":"Adipocyte"},{"key":"652_CR108","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3389\/fimmu.2019.02555","volume":"10","author":"J Surendar","year":"2019","unstructured":"Surendar, J. et al. Adiponectin limits IFN-\u03b3- and IL-17-producing CD4+ T cells in obesity by restraining cell-intrinsic glycolysis. Front Immunol. 10, 2555 (2019).","journal-title":"Front Immunol."},{"key":"652_CR109","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","volume":"1","author":"M Angin","year":"2019","unstructured":"Angin, M. et al. Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat. Metab. 1, 704\u2013716 (2019).","journal-title":"Nat. Metab."},{"key":"652_CR110","doi-asserted-by":"crossref","unstructured":"Alrubayyi, A. et al. Functional restoration of exhausted CD8+ T cells in chronic HIV-1 infection by targeting mitochondrial dysfunction. Front Immunol. 13, 908697 (2022).","DOI":"10.3389\/fimmu.2022.908697"},{"key":"652_CR111","doi-asserted-by":"crossref","unstructured":"Ellery, P. J. et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581\u20136589 (2007).","DOI":"10.4049\/jimmunol.178.10.6581"},{"key":"652_CR112","doi-asserted-by":"publisher","first-page":"e68376","DOI":"10.1371\/journal.pone.0068376","volume":"8","author":"CA Barrero","year":"2013","unstructured":"Barrero, C. A. et al. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS ONE 8, e68376 (2013).","journal-title":"PLoS ONE"},{"key":"652_CR113","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/infdis\/jiz118","volume":"220","author":"C Godfrey","year":"2019","unstructured":"Godfrey, C. et al. Obesity and fat metabolism in human immunodeficiency virus-infected individuals: immunopathogenic mechanisms and clinical implications. J. Infect. Dis. 220, 420\u2013431 (2019).","journal-title":"J. Infect. Dis."},{"key":"652_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.01.001","volume":"28","author":"M Aounallah","year":"2016","unstructured":"Aounallah, M. et al. Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects. Cytokine Growth Factor Rev. 28, 1\u201310 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"652_CR115","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11904-020-00484-4","volume":"17","author":"TR Butterfield","year":"2020","unstructured":"Butterfield, T. R., Landay, A. L. & Anzinger, J. J. Dysfunctional immunometabolism in HIV infection: contributing factors and implications for age-related comorbid diseases. Curr. HIV\/AIDS Rep. 17, 125\u2013137 (2020).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"652_CR116","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/QAI.0000000000001559","volume":"77","author":"JJ Anzinger","year":"2018","unstructured":"Anzinger, J. J. et al. Glut1 expression level on inflammatory monocytes is associated with markers of cardiovascular disease risk in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 77, e28\u2013e30 (2018).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"652_CR117","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/QAD.0000000000001320","volume":"31","author":"TR Butterfield","year":"2017","unstructured":"Butterfield, T. R. et al. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS 31, 199\u2013205 (2017).","journal-title":"AIDS"},{"key":"652_CR118","doi-asserted-by":"publisher","unstructured":"Butterfield, T. R. et al. Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus. AIDS https:\/\/doi.org\/10.1097\/qad.0000000000003272 (2022).","DOI":"10.1097\/qad.0000000000003272"},{"key":"652_CR119","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/QAD.0000000000000739","volume":"29","author":"A Maisa","year":"2015","unstructured":"Maisa, A. et al. Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. AIDS 29, 1445\u20131457 (2015).","journal-title":"AIDS"},{"key":"652_CR120","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ebiom.2019.07.027","volume":"46","author":"J Alzahrani","year":"2019","unstructured":"Alzahrani, J. et al. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. EBioMedicine 46, 522\u2013531 (2019).","journal-title":"EBioMedicine"},{"key":"652_CR121","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"652_CR122","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan, R. Y. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 34, 634\u2013648 (2022).","journal-title":"Cell Metab."},{"key":"652_CR123","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408\u2013415 (2011).","journal-title":"Nat. Immunol."},{"key":"652_CR124","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","volume":"71","author":"J Gorwood","year":"2020","unstructured":"Gorwood, J. et al. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes. Clin. Infect. Dis. 71, e549\u2013e560 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"652_CR125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/QAD.0000000000002900","volume":"35","author":"JP Bastard","year":"2021","unstructured":"Bastard, J. P. et al. Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir\/maraviroc. AIDS 35, 1625\u20131630 (2021).","journal-title":"AIDS"},{"key":"652_CR126","doi-asserted-by":"publisher","first-page":"17986","DOI":"10.1074\/jbc.RA120.015138","volume":"295","author":"CD Heer","year":"2020","unstructured":"Heer, C. D. et al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: an actionable component of innate immunity. J. Biol. Chem. 295, 17986\u201317996 (2020).","journal-title":"J. Biol. Chem."},{"key":"652_CR127","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1101\/gad.335109.119","volume":"34","author":"MS Cohen","year":"2020","unstructured":"Cohen, M. S. Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family. Genes Dev. 34, 254\u2013262 (2020).","journal-title":"Genes Dev."},{"key":"652_CR128","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","volume":"17","author":"N Stefan","year":"2021","unstructured":"Stefan, N., Birkenfeld, A. L. & Schulze, M. B. Global pandemics interconnected\u2014obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 17, 135\u2013149 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"652_CR129","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"652_CR130","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3\u201320 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"652_CR131","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ebiom.2019.04.050","volume":"43","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K\/Akt pathway in hepatic sinusoidal endothelial cells. EBioMedicine 43, 525\u2013536 (2019).","journal-title":"EBioMedicine"},{"key":"652_CR132","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1158\/0008-5472.CAN-08-2614","volume":"68","author":"Y Cao","year":"2008","unstructured":"Cao, Y. et al. Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res. 68, 8667\u20138672 (2008).","journal-title":"Cancer Res."},{"key":"652_CR133","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1021\/bi8000352","volume":"47","author":"S Banerjee","year":"2008","unstructured":"Banerjee, S. et al. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1\u2013PI3K axis. Biochemistry 47, 3345\u20133351 (2008).","journal-title":"Biochemistry"},{"key":"652_CR134","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856\u2013860 (2020).","journal-title":"Science"},{"key":"652_CR135","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"CT Wu","year":"2021","unstructured":"Wu, C. T. et al. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 33, 1565\u20131576 (2021).","journal-title":"Cell Metab."},{"key":"652_CR136","doi-asserted-by":"publisher","first-page":"e151551","DOI":"10.1172\/jci.insight.151551","volume":"6","author":"MMF Qadir","year":"2021","unstructured":"Qadir, M. M. F. et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight 6, e151551 (2021).","journal-title":"JCI Insight"},{"key":"652_CR137","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895 (2022).","journal-title":"Cell"},{"key":"652_CR138","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","volume":"3","author":"JA M\u00fcller","year":"2021","unstructured":"M\u00fcller, J. A. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149\u2013165 (2021).","journal-title":"Nat. Metab."},{"key":"652_CR139","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","volume":"3","author":"L Montefusco","year":"2021","unstructured":"Montefusco, L. et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 3, 774\u2013785 (2021).","journal-title":"Nat. Metab."},{"key":"652_CR140","doi-asserted-by":"publisher","first-page":"102302","DOI":"10.1016\/j.dsx.2021.102302","volume":"15","author":"J Mittal","year":"2021","unstructured":"Mittal, J. et al. High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case\u2013control study. Diabetes Metab. Syndr. 15, 102302 (2021).","journal-title":"Diabetes Metab. Syndr."},{"key":"652_CR141","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s42255-022-00552-6","volume":"4","author":"N Wanner","year":"2022","unstructured":"Wanner, N. et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat. Metab. 4, 310\u2013319 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR142","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","volume":"2","author":"C Wei","year":"2020","unstructured":"Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391\u20131400 (2020).","journal-title":"Nat. Metab."},{"key":"652_CR143","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s42255-022-00554-4","volume":"4","author":"E Barnes","year":"2022","unstructured":"Barnes, E. Infection of liver hepatocytes with SARS-CoV-2. Nat. Metab. 4, 301\u2013302 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR144","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113 (2021).","journal-title":"Nature"},{"key":"652_CR145","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.cmet.2021.09.009","volume":"33","author":"M Reiterer","year":"2021","unstructured":"Reiterer, M. et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 33, 2174\u20132188 (2021).","journal-title":"Cell Metab."},{"key":"652_CR146","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s42003-022-03503-9","volume":"5","author":"A Olivo","year":"2022","unstructured":"Olivo, A. et al. Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque. Commun. Biol. 5, 542 (2022).","journal-title":"Commun. Biol."},{"key":"652_CR147","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2337\/dbi20-0019","volume":"69","author":"AG Obukhov","year":"2020","unstructured":"Obukhov, A. G. et al. SARS-CoV-2 infections and ACE2: clinical outcomes linked with increased morbidity and mortality in individuals with diabetes. Diabetes 69, 1875\u20131886 (2020).","journal-title":"Diabetes"},{"key":"652_CR148","doi-asserted-by":"publisher","first-page":"e0266809","DOI":"10.1371\/journal.pone.0266809","volume":"17","author":"F Qeadan","year":"2022","unstructured":"Qeadan, F. et al. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS ONE 17, e0266809 (2022).","journal-title":"PLoS ONE"},{"key":"652_CR149","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1210\/clinem\/dgab792","volume":"107","author":"A Laurenzi","year":"2022","unstructured":"Laurenzi, A. et al. No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J. Clin. Endocrinol. Metab. 107, e1009\u2013e1019 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"652_CR150","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12890-021-01413-w","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Elevated glucose level leads to rapid COVID-19 progression and high fatality. BMC Pulm. Med. 21, 64 (2021).","journal-title":"BMC Pulm. Med."},{"key":"652_CR151","doi-asserted-by":"publisher","first-page":"e001476","DOI":"10.1136\/bmjdrc-2020-001476","volume":"8","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res. Care 8, e001476 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"652_CR152","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s42255-021-00508-2","volume":"4","author":"L Wan","year":"2022","unstructured":"Wan, L. et al. GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia. Nat. Metab. 4, 29\u201343 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR153","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s42255-021-00479-4","volume":"3","author":"J Chu","year":"2021","unstructured":"Chu, J. et al. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat. Metab. 3, 1466\u20131475 (2021).","journal-title":"Nat. Metab."},{"key":"652_CR154","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41392-021-00651-y","volume":"6","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity. Signal Transduct. Target Ther. 6, 231 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"652_CR155","doi-asserted-by":"publisher","first-page":"e78200","DOI":"10.7554\/eLife.78200","volume":"11","author":"PE Scherer","year":"2022","unstructured":"Scherer, P. E., Kirwan, J. P. & Rosen, C. J. Post-acute sequelae of COVID-19: a metabolic perspective. eLife 11, e78200 (2022).","journal-title":"eLife"},{"key":"652_CR156","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/JLB.4COVA1121-579RR","volume":"112","author":"U Zankharia","year":"2022","unstructured":"Zankharia, U., Yadav, A., Yi, Y., Hahn, B. H. & Collman, R. G. Highly restricted SARS-CoV-2 receptor expression and resistance to infection by primary human monocytes and monocyte-derived macrophages. J. Leukoc. Biol. 112, 569\u2013576 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"652_CR157","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira, C. et al. Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576\u2013584 (2022).","journal-title":"Nature"},{"key":"652_CR158","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41587-021-01020-4","volume":"40","author":"JW Lee","year":"2022","unstructured":"Lee, J. W. et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat. Biotechnol. 40, 110\u2013120 (2022).","journal-title":"Nat. Biotechnol."},{"key":"652_CR159","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31, 1068\u20131077 (2020).","journal-title":"Cell Metab."},{"key":"652_CR160","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s42255-022-00567-z","volume":"4","author":"L Tong","year":"2022","unstructured":"Tong, L. et al. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nat. Metab. 4, 547\u2013558 (2022).","journal-title":"Nat. Metab."},{"key":"652_CR161","doi-asserted-by":"publisher","first-page":"e210003","DOI":"10.20900\/immunometab20210003","volume":"3","author":"AD Proal","year":"2021","unstructured":"Proal, A. D. & VanElzakker, M. B. Pathogens hijack host cell metabolism: intracellular infection as a driver of the warburg effect in cancer and other chronic inflammatory conditions. Immunometabolism 3, e210003 (2021).","journal-title":"Immunometabolism"},{"key":"652_CR162","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/v11020141","volume":"11","author":"MA Prusinkiewicz","year":"2019","unstructured":"Prusinkiewicz, M. A. & Mymryk, J. S. Metabolic reprogramming of the host cell by human adenovirus infection. Viruses 11, 141 (2019).","journal-title":"Viruses"},{"key":"652_CR163","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.tim.2021.12.011","volume":"30","author":"J Foo","year":"2022","unstructured":"Foo, J., Bellot, G., Pervaiz, S. & Alonso, S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 30, 679\u2013692 (2022).","journal-title":"Trends Microbiol."},{"key":"652_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14250","volume":"8","author":"EM Blais","year":"2017","unstructured":"Blais, E. M. et al. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nat. Commun. 8, 14250 (2017).","journal-title":"Nat. Commun."},{"key":"652_CR165","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1152\/japplphysiol.00683.2020","volume":"130","author":"KNZ Fuller","year":"2021","unstructured":"Fuller, K. N. Z. & Thyfault, J. P. Barriers in translating preclinical rodent exercise metabolism findings to human health. J. Appl Physiol. 130, 182\u2013192 (2021).","journal-title":"J. Appl Physiol."},{"key":"652_CR166","doi-asserted-by":"publisher","first-page":"26263","DOI":"10.18632\/aging.202422","volume":"12","author":"L Omarjee","year":"2020","unstructured":"Omarjee, L. et al. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging 12, 26263\u201326278 (2020).","journal-title":"Aging"},{"key":"652_CR167","doi-asserted-by":"publisher","first-page":"e01091","DOI":"10.1002\/cti2.1091","volume":"8","author":"KM Quinn","year":"2019","unstructured":"Quinn, K. M., Palchaudhuri, R., Palmer, C. S. & La Gruta, N. L. The clock is ticking: the impact of ageing on T cell metabolism. Clin. Transl. Immunol. 8, e01091 (2019).","journal-title":"Clin. Transl. Immunol."},{"key":"652_CR168","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"MV Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier, M. V. et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun. Biol. 4, 711 (2021).","journal-title":"Commun. Biol."},{"key":"652_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/srep37005","volume":"6","author":"MK Auer","year":"2016","unstructured":"Auer, M. K. et al. 12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study. Sci. Rep. 6, 37005 (2016).","journal-title":"Sci. Rep."},{"key":"652_CR170","doi-asserted-by":"publisher","first-page":"102775","DOI":"10.1016\/j.autrev.2021.102775","volume":"20","author":"RSJ Manuel","year":"2021","unstructured":"Manuel, R. S. J. & Liang, Y. Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine. Autoimmun. Rev. 20, 102775 (2021).","journal-title":"Autoimmun. Rev."},{"key":"652_CR171","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41387-017-0003-z","volume":"7","author":"IGM van Valkengoed","year":"2017","unstructured":"van Valkengoed, I. G. M. et al. Ethnic differences in metabolite signatures and type 2 diabetes: a nested case\u2013control analysis among people of South Asian, African and European origin. Nutr. Diabetes 7, 300 (2017).","journal-title":"Nutr. Diabetes"},{"key":"652_CR172","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/hep.22387","volume":"48","author":"C Palmer","year":"2008","unstructured":"Palmer, C., Hampartzoumian, T., Lloyd, A. & Zekry, A. A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection. Hepatology 48, 374\u2013384 (2008).","journal-title":"Hepatology"},{"key":"652_CR173","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gut.2008.165316","volume":"59","author":"C Palmer","year":"2010","unstructured":"Palmer, C. et al. The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut 59, 397\u2013404 (2010).","journal-title":"Gut"},{"key":"652_CR174","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1053\/jhep.2003.50350","volume":"38","author":"BL Bressler","year":"2003","unstructured":"Bressler, B. L., Guindi, M., Tomlinson, G. & Heathcote, J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 38, 639\u2013644 (2003).","journal-title":"Hepatology"},{"key":"652_CR175","doi-asserted-by":"publisher","first-page":"e4345","DOI":"10.1093\/cid\/ciaa928","volume":"73","author":"HE Maier","year":"2021","unstructured":"Maier, H. E. et al. Obesity is associated with increased susceptibility to influenza a (H1N1pdm) but Not H3N2 Infection. Clin. Infect. Dis. 73, e4345\u2013e4352 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"652_CR176","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","volume":"29","author":"C Tanes","year":"2021","unstructured":"Tanes, C. et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe 29, 394\u2013407 (2021).","journal-title":"Cell Host Microbe"},{"key":"652_CR177","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","volume":"604","author":"R Gacesa","year":"2022","unstructured":"Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732\u2013739 (2022).","journal-title":"Nature"},{"key":"652_CR178","doi-asserted-by":"publisher","unstructured":"Hurst, J. H. et al. Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents and young adults. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciac184 (2022).","DOI":"10.1093\/cid\/ciac184"},{"key":"652_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01168-w","volume":"9","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM. Microbiome 9, 237 (2021).","journal-title":"Microbiome"},{"key":"652_CR180","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/1873-3468.12843","volume":"591","author":"CS Palmer","year":"2017","unstructured":"Palmer, C. S. et al. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection. FEBS Lett. 591, 3319\u20133332 (2017).","journal-title":"FEBS Lett."},{"key":"652_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24077-w","volume":"12","author":"LB Giron","year":"2021","unstructured":"Giron, L. B. et al. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat. Commun. 12, 3922 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR182","doi-asserted-by":"publisher","unstructured":"Varco-Merth, B. D. et al. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci156063 (2022).","DOI":"10.1172\/jci156063"},{"key":"652_CR183","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.4049\/jimmunol.1600120","volume":"196","author":"CS Palmer","year":"2016","unstructured":"Palmer, C. S. et al. Emerging role and characterization of immunometabolism: relevance to HIV pathogenesis, serious non-AIDS events, and a cure. J. Immunol. 196, 4437\u20134444 (2016).","journal-title":"J. Immunol."},{"key":"652_CR184","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/ajt.16958","volume":"22","author":"GS Netti","year":"2022","unstructured":"Netti, G. S. et al. mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients. Am. J. Transpl. 22, 1475\u20131482 (2022).","journal-title":"Am. J. Transpl."},{"key":"652_CR185","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/antiox10030416","volume":"10","author":"Y Garcia-Mesa","year":"2021","unstructured":"Garcia-Mesa, Y. et al. Dimethyl fumarate, an approved multiple sclerosis treatment, reduces brain oxidative stress in SIV-infected rhesus macaques: potential therapeutic repurposing for HIV neuroprotection. Antioxidants 10, 416 (2021).","journal-title":"Antioxidants"},{"key":"652_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58468-8","volume":"10","author":"A Hitakarun","year":"2020","unstructured":"Hitakarun, A. et al. Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus. Sci. Rep. 10, 1499 (2020).","journal-title":"Sci. Rep."},{"key":"652_CR187","doi-asserted-by":"publisher","first-page":"854241","DOI":"10.3389\/fcimb.2022.854241","volume":"12","author":"A Caputo","year":"2022","unstructured":"Caputo, A., Guzman, C. A., Palmer, C. S. & Nicoli, F. Editorial: the role of systemic and cellular metabolism on susceptibility to infections and responsiveness to vaccination. Front. Cell. Infect. Microbiol. 12, 854241 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"652_CR188","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1093\/cid\/ciab107","volume":"73","author":"CO Hileman","year":"2021","unstructured":"Hileman, C. O. et al. Plasma citrate and succinate are associated with neurocognitive impairment in older people with HIV. Clin. Infect. Dis. 73, e765\u2013e772 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"652_CR189","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ebiom.2017.07.015","volume":"22","author":"HL Yeoh","year":"2017","unstructured":"Yeoh, H. L. et al. Immunometabolic and lipidomic markers associated with the frailty index and quality of life in aging HIV+ men on antiretroviral therapy. EBioMedicine 22, 112\u2013121 (2017).","journal-title":"EBioMedicine"},{"key":"652_CR190","doi-asserted-by":"publisher","first-page":"e03444","DOI":"10.1128\/mBio.03444-20","volume":"12","author":"LB Giron","year":"2021","unstructured":"Giron, L. B. et al. Phospholipid metabolism is associated with time to HIV rebound upon treatment interruption. mBio 12, e03444\u201320 (2021).","journal-title":"mBio"},{"key":"652_CR191","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebiom.2019.03.004","volume":"42","author":"L Tarancon-Diez","year":"2019","unstructured":"Tarancon-Diez, L. et al. Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection. EBioMedicine 42, 86\u201396 (2019).","journal-title":"EBioMedicine"},{"key":"652_CR192","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s42003-020-1027-9","volume":"3","author":"PJ Ahl","year":"2020","unstructured":"Ahl, P. J. et al. Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations. Commun. Biol. 3, 305 (2020).","journal-title":"Commun. Biol."},{"key":"652_CR193","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-0716-0802-9_15","volume":"2184","author":"JJR Masson","year":"2020","unstructured":"Masson, J. J. R. et al. The multiparametric analysis of mitochondrial dynamics in T cells from cryopreserved peripheral blood mononuclear cells. Methods Mol. Biol. 2184, 215\u2013224 (2020).","journal-title":"Methods Mol. Biol."},{"key":"652_CR194","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-0716-1311-5_24","volume":"2285","author":"F Carbone","year":"2021","unstructured":"Carbone, F. et al. Metabolomics, lipidomics and immunometabolism. Methods Mol. Biol. 2285, 319\u2013328 (2021).","journal-title":"Methods Mol. Biol."},{"key":"652_CR195","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41423-021-00783-9","volume":"19","author":"V Purohit","year":"2022","unstructured":"Purohit, V., Wagner, A., Yosef, N. & Kuchroo, V. K. Systems-based approaches to study immunometabolism. Cell Mol. Immunol. 19, 409\u2013420 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"652_CR196","first-page":"e190008","volume":"1","author":"A Weinstock","year":"2019","unstructured":"Weinstock, A. et al. Single-cell RNA sequencing of visceral adipose tissue leukocytes reveals that caloric restriction following obesity promotes the accumulation of a distinct macrophage population with features of phagocytic cells. Immunometabolism 1, e190008 (2019).","journal-title":"Immunometabolism"},{"key":"652_CR197","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s42255-019-0160-6","volume":"2","author":"EL Goldberg","year":"2020","unstructured":"Goldberg, E. L. et al. Ketogenesis activates metabolically protective \u03b3\u03b4 T cells in visceral adipose tissue. Nat. Metab. 2, 50\u201361 (2020).","journal-title":"Nat. Metab."},{"key":"652_CR198","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.immuni.2021.02.018","volume":"54","author":"LS Levine","year":"2021","unstructured":"Levine, L. S. et al. Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response. Immunity 54, 829\u2013844 (2021).","journal-title":"Immunity"},{"key":"652_CR199","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.crmeth.2022.100192","volume":"2","author":"SGS Verberk","year":"2022","unstructured":"Verberk, S. G. S. et al. An integrated toolbox to profile macrophage immunometabolism. Cell Rep. Methods 2, 100192 (2022).","journal-title":"Cell Rep. Methods"},{"key":"652_CR200","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","volume":"32","author":"RJ Arg\u00fcello","year":"2020","unstructured":"Arg\u00fcello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063\u20131075 (2020).","journal-title":"Cell Metab."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00652-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T08:34:24Z","timestamp":1701246864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":200,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1038\/s42255-022-00652-3","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}